Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Neoantigenic potential of complex chromosomal rearrangements in mesothelioma.

Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, Bungum AO, Edell ES, Dong H, Cheville JC, Aubry MC, Jen J, Vasmatzis G.

J Thorac Oncol. 2018 Oct 10. pii: S1556-0864(18)33179-4. doi: 10.1016/j.jtho.2018.10.001. [Epub ahead of print]

2.

Reprint of: Pathologic manifestations of Immunoglobulin(Ig)G4-related lung disease.

Yi ES, Sekiguchi H, Peikert T, Ryu JH, Colby TV.

Semin Diagn Pathol. 2018 Sep 8. pii: S0740-2570(18)30077-7. doi: 10.1053/j.semdp.2018.09.004. [Epub ahead of print]

PMID:
30249368
3.

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions.

Clay R, Rajagopalan S, Karwoski R, Maldonado F, Peikert T, Bartholmai B.

Transl Lung Cancer Res. 2018 Jun;7(3):313-326. doi: 10.21037/tlcr.2018.05.11. Review.

4.

Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R.

J Thorac Oncol. 2018 Sep;13(9):1269-1283. doi: 10.1016/j.jtho.2018.06.011. Review.

PMID:
29966799
5.

Assessment of Interstitial Lung Disease Using Lung Ultrasound Surface Wave Elastography: A Novel Technique With Clinicoradiologic Correlates.

Clay R, Bartholmai BJ, Zhou B, Karwoski R, Peikert T, Osborn T, Rajagopalan S, Kalra S, Zhang X.

J Thorac Imaging. 2018 Jun 5. doi: 10.1097/RTI.0000000000000334. [Epub ahead of print]

PMID:
29877916
6.

Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.

Nakajima EC, Frankland MP, Johnson TF, Antic SL, Chen H, Chen SC, Karwoski RA, Walker R, Landman BA, Clay RD, Bartholmai BJ, Rajagopalan S, Peikert T, Massion PP, Maldonado F.

PLoS One. 2018 Jun 1;13(6):e0198118. doi: 10.1371/journal.pone.0198118. eCollection 2018.

7.

Effects of Reduction in Tumor Burden on Survival in Epithelioid Malignant Pleural Mesothelioma.

Mansfield AS, Peikert T, Vogelzang NJ, Symanowski JT.

Mayo Clin Proc. 2018 Aug;93(8):1026-1033. doi: 10.1016/j.mayocp.2018.01.032. Epub 2018 May 24.

PMID:
29804728
8.

Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

Peikert T, Duan F, Rajagopalan S, Karwoski RA, Clay R, Robb RA, Qin Z, Sicks J, Bartholmai BJ, Maldonado F.

PLoS One. 2018 May 14;13(5):e0196910. doi: 10.1371/journal.pone.0196910. eCollection 2018. Erratum in: PLoS One. 2018 Oct 2;13(10):e0205311.

9.

Progress in the Management of Malignant Pleural Mesothelioma in 2017.

McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T.

J Thorac Oncol. 2018 May;13(5):606-623. doi: 10.1016/j.jtho.2018.02.021. Epub 2018 Mar 8. Review.

PMID:
29524617
10.

While size matters-advanced "Radiomics" remain promising for the clinical management of ground glass opacities.

Peikert T, Rajagopalan S, Bartholmai B, Maldonado F.

J Thorac Dis. 2017 Oct;9(10):3568-3571. doi: 10.21037/jtd.2017.09.56. No abstract available.

11.

Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.

Clay R, Kipp BR, Jenkins S, Karwoski RA, Maldonado F, Rajagopalan S, Voss JS, Bartholmai BJ, Aubry MC, Peikert T.

Sci Rep. 2017 Dec 15;7(1):17620. doi: 10.1038/s41598-017-17659-6.

12.

Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma.

Terra SBSP, Mansfield AS, Dong H, Peikert T, Roden AC.

Oncoimmunology. 2017 Jul 27;6(11):e1356146. doi: 10.1080/2162402X.2017.1356146. eCollection 2017.

13.

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.

Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, Yi ES, Peikert T, Aubry MC, Roden AC.

Am J Surg Pathol. 2018 Feb;42(2):256-263. doi: 10.1097/PAS.0000000000000976.

PMID:
29076876
14.

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

Pennington K, Sasieta HC, Ramos GP, Erskine CL, Van Keulen VP, Peikert T, Escalante P.

Clin Med Insights Case Rep. 2017 Aug 24;10:1179547617724776. doi: 10.1177/1179547617724776. eCollection 2017.

15.

Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls.

Cornec D, Berti A, Hummel A, Peikert T, Pers JO, Specks U.

J Autoimmun. 2017 Nov;84:122-131. doi: 10.1016/j.jaut.2017.08.006. Epub 2017 Sep 1.

PMID:
28870527
16.

Bronchoscopic Management of Airway Compression due to Fibrosing Mediastinitis.

Kern R, Peikert T, Edell E, Mullon J, Midthun D, Utz J, Maldonado F.

Ann Am Thorac Soc. 2017 Aug;14(8):1353-1355. doi: 10.1513/AnnalsATS.201610-782RL. No abstract available.

PMID:
28719233
17.

Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways.

Ali MF, Dasari H, Van Keulen VP, Cornec D, Vasmatzis G, Peikert T, Carmona EM.

Sci Rep. 2017 Jun 20;7(1):3869. doi: 10.1038/s41598-017-04199-2.

18.

Management of Multifocal Lung Cancer: Results of a Survey.

Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS.

J Thorac Oncol. 2017 Sep;12(9):1398-1402. doi: 10.1016/j.jtho.2017.05.013. Epub 2017 Jun 3.

19.

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.

Bhinge K, Yang L, Terra S, Nasir A, Muppa P, Aubry MC, Yi J, Janaki N, Kovtun IV, Murphy SJ, Halling G, Rahi H, Mansfield A, de Andrade M, Yang P, Vasmatzis G, Peikert T, Kosari F.

Oncotarget. 2017 Apr 18;8(16):27155-27165. doi: 10.18632/oncotarget.15676.

20.

Appreciating the shades of gray: a case for Computer-Aided Nodule Assessment and Risk Yield (CANARY)-based risk stratification of lung adenocarcinomas.

Maldonado F, Peikert T, Bartholmai BJ, Rajagopalan S, Karwoski RA.

J Thorac Dis. 2016 Oct;8(10):E1438-E1440. No abstract available.

Supplemental Content

Loading ...
Support Center